How proteomics reveals potential biomarkers in brain diseases (Q36322155)

13 August 2017

1 reference

title

How proteomics reveals potential biomarkers in brain diseases (English)

1 reference

13 August 2017

0 references

Oliver Schmidt

1

1 reference

13 August 2017

Thomas Schulenborg

2

1 reference

13 August 2017

Helmut E Meyer

3

1 reference

13 August 2017

Katrin Marcus

4

1 reference

13 August 2017

Michael Hamacher

5

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Expert Review of Proteomics

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

901-913

1 reference

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

CSF proteome: a protein repository for potential biomarker identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The need for a public proteomics repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Between-gel reproducibility of the human cerebrospinal fluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

HBPP and the pursuit of standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

HUPO Brain Proteome Project: aims and needs in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

How industry is approaching the search for new diagnostic markers and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Postmortem changes in the level of brain proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Organelle proteomics of rat synaptic proteins: correlation-profiling by isotope-coded affinity tagging in conjunction with liquid chromatography-tandem mass spectrometry to reveal post-synaptic density specific proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Peptidomics-Based Discovery of Novel Neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Sodium dodecyl sulfate-gel electrophoresis: staining of polypeptides using heavy metal salts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Multi-dimensional liquid phase based separations in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Multidimensional peptide separations in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

An automated multidimensional protein identification technology for shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Electrospray ionization for mass spectrometry of large biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Ionization in matrix-assisted laser desorption/ionization: singly charged molecular ions are the lucky survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Mass spectrometry in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Probability-based protein identification by searching sequence databases using mass spectrometry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

ProFound: an expert system for protein identification using mass spectrometric peptide mapping information

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Peptide sequencing by matrix-assisted laser-desorption mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Brain ubiquitin is markedly elevated in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Identification of oxidized plasma proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteome analysis of human substantia nigra in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Genetic clues to the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Yeast cells provide insight into alpha-synuclein biology and pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The ubiquitin pathway in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

UCHL1 is a Parkinson's disease susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

21 January 2018

Pathways to Parkinsonism

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Proteomic approaches in brain research and neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Neuroproteomics: expression profiling of the brain's proteomes in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Effects on rat thalamic proteome by acute and subchronic MK-801-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Glutamatergic mechanisms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Standards for microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

HUPO initiatives relevant to clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Building a foundation for the human proteome: the role of the Human Proteome Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

IntAct: an open source molecular interaction database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Common interchange standards for proteomics data: Public availability of tools and schema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

"Does understanding the brain need proteomics and does understanding proteomics need brains?"--Second HUPO HBPP Workshop hosted in Paris

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.2.6.901

21 January 2018

Identifiers

DOI

10.1586/14789450.2.6.901

1 reference

13 August 2017

1 reference